470 related articles for article (PubMed ID: 22694310)
1. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
2. Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.
Szlachcic WJ; Switonski PM; Krzyzosiak WJ; Figlerowicz M; Figiel M
Dis Model Mech; 2015 Sep; 8(9):1047-57. PubMed ID: 26092128
[TBL] [Abstract][Full Text] [Related]
3. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
4. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.
Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H
Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.
McQuade LR; Balachandran A; Scott HA; Khaira S; Baker MS; Schmidt U
J Proteome Res; 2014 Dec; 13(12):5648-59. PubMed ID: 25316320
[TBL] [Abstract][Full Text] [Related]
6. Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.
Chiu FL; Lin JT; Chuang CY; Chien T; Chen CM; Chen KH; Hsiao HY; Lin YS; Chern Y; Kuo HC
Hum Mol Genet; 2015 Nov; 24(21):6066-79. PubMed ID: 26264576
[TBL] [Abstract][Full Text] [Related]
7. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
[TBL] [Abstract][Full Text] [Related]
8. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
9. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Huntington monkey skin cells into pluripotent stem cells.
Chan AW; Cheng PH; Neumann A; Yang JJ
Cell Reprogram; 2010 Oct; 12(5):509-17. PubMed ID: 20936902
[TBL] [Abstract][Full Text] [Related]
11. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress causes DNA triplet expansion in Huntington's disease mouse embryonic stem cells.
Jonson I; Ougland R; Klungland A; Larsen E
Stem Cell Res; 2013 Nov; 11(3):1264-71. PubMed ID: 24041806
[TBL] [Abstract][Full Text] [Related]
13. Modeling Huntington's disease with induced pluripotent stem cells.
Kaye JA; Finkbeiner S
Mol Cell Neurosci; 2013 Sep; 56():50-64. PubMed ID: 23459227
[TBL] [Abstract][Full Text] [Related]
14. Huntington's disease: dancing in a dish.
Zhang K; Yi F; Liu GH; Izpisua Belmonte JC
Cell Res; 2012 Dec; 22(12):1627-30. PubMed ID: 22868272
[TBL] [Abstract][Full Text] [Related]
15. Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations.
Irmak D; Fatima A; Gutiérrez-Garcia R; Rinschen MM; Wagle P; Altmüller J; Arrigoni L; Hummel B; Klein C; Frese CK; Sawarkar R; Rada-Iglesias A; Vilchez D
Hum Mol Genet; 2018 Dec; 27(23):4117-4134. PubMed ID: 30452683
[TBL] [Abstract][Full Text] [Related]
16. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
[TBL] [Abstract][Full Text] [Related]
17. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
Geater C; Hernandez S; Thompson L; Mattis VB
Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
[TBL] [Abstract][Full Text] [Related]
18. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.
Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW
Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
Castiglioni V; Onorati M; Rochon C; Cattaneo E
Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
